Roivant Sciences (ROIV) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Roivant Sciences (ROIV) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Roivant Sciences | 24.78 Bn | 24.78 Bn | 1.16 Mn | 720.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 720.78 Mn |
| Mar 31, 2026 | 693.86 Mn |
| Dec 31, 2025 | 696.86 Mn |
| Sep 30, 2025 | 680.95 Mn |
| Jun 30, 2025 | 680.29 Mn |
| Mar 31, 2025 | 725.40 Mn |
| Dec 31, 2024 | 722.72 Mn |
| Sep 30, 2024 | 735.47 Mn |
| Jun 30, 2024 | 781.63 Mn |
| Mar 31, 2024 | 831.05 Mn |
| Dec 31, 2023 | 844.46 Mn |
| Sep 30, 2023 | 770.23 Mn |
| Jun 30, 2023 | 759.27 Mn |
| Mar 31, 2023 | 712.79 Mn |
| Dec 31, 2022 | 713.32 Mn |
| Sep 30, 2022 | 699.89 Mn |
| Jun 30, 2022 | 695.88 Mn |
| Mar 31, 2022 | 669.75 Mn |
| Dec 31, 2021 | 686.59 Mn |
| Sep 30, 2021 | 650.23 Mn |